GCP
MDT icon

Garda Capital Partners’s Medtronic MDT Stock Holding History

Garda Capital Partners’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,392
Closed -$296K – 282
2025
Q2 		$296K Buy
+3,392
New +$288K 0.01% 516
2023
Q4 		– Sell
-21,850
Closed -$1.71M – 614
2023
Q3 		$1.71M Buy
+21,850
New +$1.83M 0.08% 256

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Garda Capital Partners's MDT Position: Q3 2025 in Review

Garda Capital Partners sold out of Medtronic (MDT) in Q3 2025, closing a stake of 3,392 shares — an estimated $296K sold.

Garda Capital Partners first reported a position in MDT in Q3 2023 and held it in 2 quarters. The position peaked at $1.71M in Q3 2023. 2,169 funds tracked by Wall St. Rank hold MDT as of Q3 2025.

  • Garda Capital Partners reported no remaining Medtronic position as of Q3 2025 after selling out during the quarter.
  • Garda Capital Partners sold 3,392 Medtronic shares in Q3 2025, an estimated $296K.
  • Garda Capital Partners first reported a position in Medtronic in Q3 2023 and held it in 2 quarters.
  • Garda Capital Partners's Medtronic position peaked at $1.71M in Q3 2023.
  • 2,169 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.

Based on Garda Capital Partners's 13F filing for Q3 2025, filed 10 Nov 2025.